Related Experiment Video
Updated: Jul 11, 2026

Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption
Published on: August 16, 2016
Adenosine receptor modulation: potential implications in veterinary medicine
1Institute of Pharmacology and Toxicology, University of Zurich-Vetsuisse, Winterthurerstrasse 260, CH-8057 Zurich, Switzerland. dip@vetpharm.uzh.ch
Adenosine, a molecule rising during inflammation, plays a key role in airway inflammation. Modulating adenosine receptors offers potential therapeutic strategies for chronic airway diseases in veterinary medicine.
Area of Science:
- Biochemistry
- Pharmacology
- Veterinary Medicine
Background:
- Adenosine concentration increases during inflammation and hypoxia.
- Airway hyperresponsiveness to adenosine is observed in asthmatic subjects, highlighting its role in airway inflammation.
- Understanding adenosine's diverse roles is crucial for developing targeted therapies.
Purpose of the Study:
- To review the effects of adenosine receptors and their intracellular signaling pathways.
- To explore the potential of adenosine receptor modulation as a therapeutic target for chronic airway inflammation.
- To discuss applications in veterinary medicine, using equine recurrent airway disease and feline asthma as models.
Main Methods:
- Review of existing literature on adenosine receptors and signaling.
- Pharmacological characterization of adenosine receptor subtypes and ligands.
- Analysis of adenosine's role in naturally occurring airway obstructive diseases in animals.
Main Results:
- Adenosine receptors and their signaling pathways are complex, with broad distribution causing potential side effects.
- Subtype-specific ligands are being developed to target adenosine's effects more precisely.
- Adenosine receptor modulation shows promise for treating conditions like equine recurrent airway disease and feline asthma.
Conclusions:
- Adenosine receptor modulation presents a potential therapeutic avenue for chronic airway inflammation.
- Further research into adenosine's mechanism of action will unlock new veterinary therapeutic approaches.
- Targeting adenosine pathways could lead to novel treatments for various animal health conditions.
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Heart Failure Drugs: Inotropic Agents
